📰 Virtual Biotech News
Page 2 - Virtual Biotech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Virtual Biotech. Real-time updates on events, politics, business and more.
October 13, 2022
PHILADELPHIA, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Enterin Inc., a privately held, Philadelphia-based, clinical-stage biopharmaceutical company developing...
September 1, 2022
“This study provides hope for an effective treatment and a step towards the longer-term goal of stopping neurodegeneration,” said Pharmaxis...
August 23, 2022
/PRNewswire/ -- The Parkinsons Foundation and Parkinsons UK, an organization based in the United Kingdom that funds research and provides life-changing...
June 30, 2022
Cambridge and Stevenage, United Kingdom, 30th June 2022 / Sciad Newswire / NRG Therapeutics Ltd., an innovative neuroscience company targeting mitochondrial dysfunction, and Domainex Ltd., today announce a collaboration focused on developing novel small molecule disease-modifying medicines for the treatment of Parki...
May 31, 2022
NRG Therapeutics announces multi-million Innovate UK Award to develop treatments for Parkinson’s and motor neurone disease - News - PharmaTimes
May 31, 2022
UK neuroscience company NRG Therapeutics Ltd has received an award to fund preclinical development of its novel small molecule disease-modifying medicines for the treatment of Parkinson's disease, motor neuron disease (MND) and other chronic neurodegenerative disorders.
May 31, 2022
NRG Therapeutics Ltd (“NRG” or “company”), an innovative neuroscience company targeting mitochondrial dysfunction, is pleased to announce that it has received a highly competitive Biomedical Catalyst (BMC) award to fund pre-clinical development of its novel small molecule disease-modifying medicines for the treatment of Parkinson's disease, motor neuron disease (MND) and other debilitating chronic neurodegenerative disorders.
May 30, 2022
/PRNewswire/ -- NRG Therapeutics Ltd ("NRG" or "company"), an innovative neuroscience company targeting mitochondrial dysfunction, is pleased to announce that...
April 11, 2022
In recognition of World Parkinson's Day, we speak to Dr. Arthur Roach, Director of Research at Parkinson’s UK, about the current Parkinson's landscape.
October 6, 2021
HAMILTON, BERMUDA / ACCESSWIRE / October 6, 2021 / Altamira Therapeutics Ltd. (NASDAQ:CYTO) ("Altamira" or the "Company"), a company dedicated to addressing unmet medical needs through RNA therapeutics